Wave Life Sciences Ltd.
OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF
Last updated:
Abstract:
Among other things, the present disclosure provides C9orf72 oligonucleotides, compositions, and methods thereof. In some embodiments, the present disclosure provides methods for treating C9orf72-associated conditions, disorders or diseases, such as amyotrophic lateral sclerosis and frontotemporal dementia.
Status:
Application
Type:
Utility
Filling date:
8 May 2020
Issue date:
12 May 2022